Inactive Instrument

Vycor Medical, Inc. Share Price Other OTC

Equities

VYCO

US92921M2035

Medical Equipment, Supplies & Distribution

Sales 2022 1.22M 97.8M Sales 2023 1.46M 117M Capitalization 2.52M 201M
Net income 2022 - 0 Net income 2023 - 0 EV / Sales 2022 3.18 x
Net Debt 2022 957K 76.52M Net Debt 2023 1.05M 84.2M EV / Sales 2023 2.45 x
P/E ratio 2022
-3.91 x
P/E ratio 2023
-6.39 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 37.09%
More Fundamentals * Assessed data
Dynamic Chart
Vycor Medical, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Vycor Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Vycor Medical, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Vycor Medical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Vycor Medical, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Vycor Medical, Inc. Auditor Raises 'Going Concern' Doubt CI
Vycor Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Vycor Medical, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Vycor Medical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Vycor Medical, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Vycor Medical, Inc. Auditor Raises 'Going Concern' Doubt CI
Vycor Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Vycor Medical, Inc. Announces Earnings Results for the Second Quarter Ended June 30, 2021 CI
Vycor Medical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
Vycor Medical, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020 CI
More news
Managers TitleAgeSince
Chief Executive Officer 62 13/05/10
President 57 31/12/09
Chairman 65 31/12/09
Members of the board TitleAgeSince
Chief Executive Officer 62 13/05/10
Chairman 65 31/12/09
President 57 31/12/09
More insiders
Vycor Medical, Inc. provides surgical and therapeutic solutions. The Company designs, develops and markets neurological medical devices and therapies. The Company operates through two segments: Vycor Medical and NovaVision. The Vycor Medical segment designs, develops and markets medical devices for use in neurosurgery. The NovaVision segment provides non-invasive rehabilitation therapies for those who have vision disorders resulting from neurological brain damage such as that caused by a stroke. Vycor Medical's product Vycor Medical's ViewSite Brain Access System (VBAS) is a next generation retraction and access system. Vycor Medical focuses on brain and cervical surgical access systems for sale to hospitals and medical professionals. NovaVision's products include Vision Restoration Therapy (VRT), NeuroEyeCoach and Neuro-Eye Therapy (NeEt). The Company operates in the United States and Europe.
More about the company